CoChat

Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study

Efe, Cumali, Ozaslan, Ersan, Wahlin, Staffan, Purnak, Tugrul, Muratori, Luigi, Quarneti, Chiara, Yüksel, Osman, Muratori, Paolo · 2013 · Liver International
Cited by 41

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Background: Antibodies to soluble liver antigen (anti‐SLA) are specific serological markers of autoimmune hepatitis (AIH). The clinical significance and frequency of anti‐SLA have never been reported among AIH patients from Italy and Turkey. To retrospectively assess the estimated prevalence, sensitivity, specificity and clinical significance of anti‐SLA in AIH and various liver diseases. Methods: A total of 986 patients who had been tested for serum anti‐SLA were included in study. The presence of anti‐SLA was detected using recombinant enzyme linked immunosorbent assay and immuno‐blot. The general characteristics and outcome of patients were obtained from their medical records. Results: Antibodies to SLA were found in 30 (3%) of 986 patients. Of these, 27 (90%) had AIH and its variants, whereas the remaining three (10%) had primary biliary cirrhosis. The prevalence of anti‐SLA was 9% in AIH patients from Italy and 15% in patients from Turkey. The specificity of these antibodies was 99.5%, whereas sensitivity was 11%. The positive predictive and negative predictive values were 90% and 77.5% respectively (95% confidence interval). Biochemical remission was achieved in 90% of anti‐SLA positive AIH patients, but relapse after immunosuppressive withdrawal or during maintenance therapy was observed in 53% of the patients. Conclusions: Seropositivity for anti‐SLA occurs at similar frequencies in AIH patients from different geographical regions and ethnic groups. The sensitivity of anti‐SLA is low, but it has high specificity for AIH. Additional studies are necessary to prove clinical significance of anti‐SLA in AIH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/liv.12022

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 41

Metadata

Authors
Efe, C., Ozaslan, E., Wahlin, S., Purnak, T., Muratori, L., Quarneti, C., Yüksel, O., & Muratori, P.
Venue
Liver International
Publisher
Wiley
Published
2013-01-07
Volume
33
Issue
2
Pages
190-196
ISSN
  • 0106-9543 (ISSN-L)
  • 1478-3223
  • 1478-3231
OpenAlex
W2150207669
Cited by
41
References
4
FWCI
2.31
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study. https://app.cochat.ai/papers/10.1111/liv.12022
The paper
Efe, C., Ozaslan, E., Wahlin, S., Purnak, T., Muratori, L., Quarneti, C., Yüksel, O., & Muratori, P. (2013). Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study. Liver International. https://doi.org/10.1111/liv.12022

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.